Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» China Approves Gilead's Genvoya for HIV-1 Infection
China Approves Gilead's Genvoya for HIV-1 Infection
China Approves Gilead's Genvoya for HIV-1 Infection
Submitted by
admin
on August 6, 2018 - 9:47am
Source:
CP Wire
News Tags:
Gilead Sciences
China
Genvoya
HIV
Headline:
China Approves Gilead's Genvoya for HIV-1 Infection
snippet:
Genvoya is the first TAF-based single tablet regimen for the treatment of HIV to be approved in China
There were approximately 140,000 people newly diagnosed with HIV in China as of 2017
Genvoya has already become the most-prescribed regimen for both treatment-naïve and switch patients
Do Not Allow Advertisers to Use My Personal information
